ID   RBSK_HUMAN              Reviewed;         322 AA.
AC   Q9H477; A9UK04; B4DV96;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 139.
DE   RecName: Full=Ribokinase {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000303|PubMed:17585908};
DE            Short=RK {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000303|PubMed:17585908};
DE            EC=2.7.1.15 {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908};
GN   Name=RBKS {ECO:0000255|HAMAP-Rule:MF_03215}; Synonyms=RBSK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wightman P.J.;
RL   Thesis (2000), University of Edinburgh, United Kingdom.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li X., Mao Y., Xie Y.;
RT   "Cloning and characterization of RBS protein.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME REGULATION.
RX   PubMed=17585908; DOI=10.1016/j.febslet.2007.06.009;
RA   Park J., van Koeverden P., Singh B., Gupta R.S.;
RT   "Identification and characterization of human ribokinase and
RT   comparison of its properties with E. coli ribokinase and human
RT   adenosine kinase.";
RL   FEBS Lett. 581:3211-3216(2007).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 11-322 IN COMPLEX WITH ADP;
RP   SODIUM AND MAGNESIUM.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human ribokinase.";
RL   Submitted (JAN-2006) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the phosphorylation of ribose at O-5 in a
CC       reaction requiring ATP and magnesium. The resulting D-ribose-5-
CC       phosphate can then be used either for sythesis of nucleotides,
CC       histidine, and tryptophan, or as a component of the pentose
CC       phosphate pathway. {ECO:0000255|HAMAP-Rule:MF_03215,
CC       ECO:0000269|PubMed:17585908}.
CC   -!- CATALYTIC ACTIVITY: ATP + D-ribose = ADP + D-ribose 5-phosphate.
CC       {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03215};
CC       Note=Requires a divalent cation, most likely magnesium in vivo, as
CC       an electrophilic catalyst to aid phosphoryl group transfer. It is
CC       the chelate of the metal and the nucleotide that is the actual
CC       substrate. {ECO:0000255|HAMAP-Rule:MF_03215};
CC   -!- ENZYME REGULATION: Activated by a monovalent cation that binds
CC       near, but not in, the active site. The most likely occupant of the
CC       site in vivo is potassium. Ion binding induces a conformational
CC       change that may alter substrate affinity (By similarity).
CC       Competitively inhibited by phosphonoacetic acid, etidronate, 2-
CC       carboxethylphosphonic acid, N-(phosphonomethyl)glycine, N-
CC       (phosphonomethyl)iminodiacetic acid and clodronate
CC       (PubMed:17585908). {ECO:0000255|HAMAP-Rule:MF_03215,
CC       ECO:0000269|PubMed:17585908}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.17 mM for ribose (in the presence of 10 mM inorganic
CC         phosphate) {ECO:0000269|PubMed:17585908};
CC         KM=3.39 mM for ribose (in the presence of 5 mM inorganic
CC         phosphate) {ECO:0000269|PubMed:17585908};
CC         KM=6.62 mM for ribose (in the presence of 2 mM inorganic
CC         phosphate) {ECO:0000269|PubMed:17585908};
CC         KM=30.43 mM for ribose (in the presence of 1 mM inorganic
CC         phosphate) {ECO:0000269|PubMed:17585908};
CC         KM=0.07 mM for ATP (in the presence of 5 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=0.08 mM for ATP (in the presence of 2 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC         KM=0.10 mM for ATP (in the presence of 1 mM inorganic phosphate)
CC         {ECO:0000269|PubMed:17585908};
CC   -!- PATHWAY: Carbohydrate metabolism; D-ribose degradation; D-ribose
CC       5-phosphate from beta-D-ribopyranose: step 2/2.
CC       {ECO:0000255|HAMAP-Rule:MF_03215}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P0A9J6,
CC       ECO:0000255|HAMAP-Rule:MF_03215}.
CC   -!- INTERACTION:
CC       Q96AP0:ACD; NbExp=2; IntAct=EBI-10982959, EBI-717666;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P25332,
CC       ECO:0000255|HAMAP-Rule:MF_03215}. Nucleus
CC       {ECO:0000250|UniProtKB:P25332, ECO:0000255|HAMAP-Rule:MF_03215}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H477-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H477-2; Sequence=VSP_054380;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the carbohydrate kinase PfkB family.
CC       Ribokinase subfamily. {ECO:0000255|HAMAP-Rule:MF_03215}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ404857; CAC12877.1; -; mRNA.
DR   EMBL; AY643715; AAT64917.1; -; mRNA.
DR   EMBL; AK300989; BAG62608.1; -; mRNA.
DR   EMBL; AC021171; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017425; AAH17425.1; -; mRNA.
DR   CCDS; CCDS1762.1; -. [Q9H477-1]
DR   RefSeq; NP_001274509.1; NM_001287580.1.
DR   RefSeq; NP_071411.1; NM_022128.2. [Q9H477-1]
DR   UniGene; Hs.11916; -.
DR   PDB; 2FV7; X-ray; 2.10 A; A/B=11-322.
DR   PDB; 5BYC; X-ray; 1.95 A; A/B=1-322.
DR   PDB; 5BYD; X-ray; 2.10 A; A/B=1-322.
DR   PDB; 5BYE; X-ray; 1.75 A; A/B=1-322.
DR   PDB; 5BYF; X-ray; 2.00 A; A/B=1-322.
DR   PDB; 5C3Y; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=1-322.
DR   PDB; 5C3Z; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 5C40; X-ray; 1.50 A; A/B=1-322.
DR   PDB; 5C41; X-ray; 1.95 A; A/B/C/D=1-322.
DR   PDBsum; 2FV7; -.
DR   PDBsum; 5BYC; -.
DR   PDBsum; 5BYD; -.
DR   PDBsum; 5BYE; -.
DR   PDBsum; 5BYF; -.
DR   PDBsum; 5C3Y; -.
DR   PDBsum; 5C3Z; -.
DR   PDBsum; 5C40; -.
DR   PDBsum; 5C41; -.
DR   ProteinModelPortal; Q9H477; -.
DR   SMR; Q9H477; -.
DR   BioGrid; 122046; 10.
DR   IntAct; Q9H477; 6.
DR   STRING; 9606.ENSP00000306817; -.
DR   iPTMnet; Q9H477; -.
DR   PhosphoSitePlus; Q9H477; -.
DR   DMDM; 20139730; -.
DR   EPD; Q9H477; -.
DR   MaxQB; Q9H477; -.
DR   PaxDb; Q9H477; -.
DR   PeptideAtlas; Q9H477; -.
DR   PRIDE; Q9H477; -.
DR   DNASU; 64080; -.
DR   Ensembl; ENST00000302188; ENSP00000306817; ENSG00000171174. [Q9H477-1]
DR   GeneID; 64080; -.
DR   KEGG; hsa:64080; -.
DR   UCSC; uc002rlo.3; human. [Q9H477-1]
DR   CTD; 64080; -.
DR   DisGeNET; 64080; -.
DR   GeneCards; RBKS; -.
DR   HGNC; HGNC:30325; RBKS.
DR   HPA; HPA019725; -.
DR   HPA; HPA028285; -.
DR   MIM; 611132; gene.
DR   neXtProt; NX_Q9H477; -.
DR   OpenTargets; ENSG00000171174; -.
DR   PharmGKB; PA134951602; -.
DR   eggNOG; KOG2855; Eukaryota.
DR   eggNOG; COG0524; LUCA.
DR   GeneTree; ENSGT00390000005743; -.
DR   HOGENOM; HOG000235950; -.
DR   HOVERGEN; HBG018350; -.
DR   InParanoid; Q9H477; -.
DR   KO; K00852; -.
DR   OMA; NDSPFVA; -.
DR   OrthoDB; EOG091G08OZ; -.
DR   PhylomeDB; Q9H477; -.
DR   TreeFam; TF105770; -.
DR   UniPathway; UPA00916; UER00889.
DR   EvolutionaryTrace; Q9H477; -.
DR   GenomeRNAi; 64080; -.
DR   PRO; PR:Q9H477; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000171174; -.
DR   ExpressionAtlas; Q9H477; baseline and differential.
DR   Genevisible; Q9H477; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019200; F:carbohydrate kinase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004747; F:ribokinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046835; P:carbohydrate phosphorylation; IBA:GO_Central.
DR   GO; GO:0019303; P:D-ribose catabolic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd01174; ribokinase; 1.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   HAMAP; MF_01987; Ribokinase; 1.
DR   InterPro; IPR002173; Carboh/pur_kinase_PfkB_CS.
DR   InterPro; IPR011877; D_ribokin.
DR   InterPro; IPR011611; PfkB_dom.
DR   InterPro; IPR002139; Ribo/fructo_kinase.
DR   InterPro; IPR029056; Ribokinase-like.
DR   Pfam; PF00294; PfkB; 1.
DR   PRINTS; PR00990; RIBOKINASE.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   TIGRFAMs; TIGR02152; D_ribokin_bact; 1.
DR   PROSITE; PS00584; PFKB_KINASES_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding;
KW   Carbohydrate metabolism; Complete proteome; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Potassium;
KW   Reference proteome; Transferase.
FT   CHAIN         1    322       Ribokinase.
FT                                /FTId=PRO_0000080092.
FT   NP_BIND     235    240       ATP. {ECO:0000255|HAMAP-Rule:MF_03215,
FT                                ECO:0000269|Ref.7}.
FT   NP_BIND     268    269       ATP. {ECO:0000255|HAMAP-Rule:MF_03215,
FT                                ECO:0000269|Ref.7}.
FT   REGION       25     27       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P0A9J6,
FT                                ECO:0000255|HAMAP-Rule:MF_03215}.
FT   REGION       53     57       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P0A9J6,
FT                                ECO:0000255|HAMAP-Rule:MF_03215}.
FT   ACT_SITE    269    269       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P0A9J6,
FT                                ECO:0000255|HAMAP-Rule:MF_03215}.
FT   METAL       263    263       Potassium. {ECO:0000255|HAMAP-
FT                                Rule:MF_03215, ECO:0000305|Ref.7}.
FT   METAL       265    265       Potassium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P0A9J6,
FT                                ECO:0000255|HAMAP-Rule:MF_03215}.
FT   METAL       301    301       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03215,
FT                                ECO:0000305|Ref.7}.
FT   METAL       304    304       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03215,
FT                                ECO:0000305|Ref.7}.
FT   METAL       306    306       Potassium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P0A9J6,
FT                                ECO:0000255|HAMAP-Rule:MF_03215}.
FT   METAL       310    310       Potassium. {ECO:0000255|HAMAP-
FT                                Rule:MF_03215, ECO:0000305|Ref.7}.
FT   BINDING     154    154       Substrate. {ECO:0000250|UniProtKB:P0A9J6,
FT                                ECO:0000255|HAMAP-Rule:MF_03215}.
FT   BINDING     199    199       ATP. {ECO:0000255|HAMAP-Rule:MF_03215,
FT                                ECO:0000269|Ref.7}.
FT   BINDING     256    256       ATP. {ECO:0000255|HAMAP-Rule:MF_03215,
FT                                ECO:0000269|Ref.7}.
FT   BINDING     269    269       Substrate. {ECO:0000250|UniProtKB:P0A9J6,
FT                                ECO:0000255|HAMAP-Rule:MF_03215}.
FT   BINDING     295    295       ATP. {ECO:0000255|HAMAP-Rule:MF_03215,
FT                                ECO:0000269|Ref.7}.
FT   VAR_SEQ     266    322       GAGDSFVGALAFYLAYYPNLSLEDMLNRSNFIAAVSVQAAG
FT                                TQSSYPYKKDLPLTLF -> CRPGSRPKSEAASVKKQKHYK
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054380.
FT   CONFLICT    101    101       T -> A (in Ref. 2; AAT64917).
FT                                {ECO:0000305}.
FT   STRAND       17     21       {ECO:0000244|PDB:5C40}.
FT   STRAND       25     31       {ECO:0000244|PDB:5C40}.
FT   STRAND       41     43       {ECO:0000244|PDB:5C40}.
FT   STRAND       45     52       {ECO:0000244|PDB:5C40}.
FT   HELIX        54     64       {ECO:0000244|PDB:5C40}.
FT   STRAND       69     78       {ECO:0000244|PDB:5C40}.
FT   HELIX        79     90       {ECO:0000244|PDB:5C40}.
FT   STRAND       98    101       {ECO:0000244|PDB:5C40}.
FT   STRAND      108    113       {ECO:0000244|PDB:5C40}.
FT   STRAND      119    124       {ECO:0000244|PDB:5C40}.
FT   HELIX       126    130       {ECO:0000244|PDB:5C40}.
FT   HELIX       133    138       {ECO:0000244|PDB:5C40}.
FT   HELIX       140    145       {ECO:0000244|PDB:5C40}.
FT   STRAND      147    151       {ECO:0000244|PDB:5C40}.
FT   STRAND      153    155       {ECO:0000244|PDB:5C40}.
FT   HELIX       157    169       {ECO:0000244|PDB:5C40}.
FT   STRAND      173    176       {ECO:0000244|PDB:5C40}.
FT   HELIX       188    191       {ECO:0000244|PDB:5C40}.
FT   STRAND      194    199       {ECO:0000244|PDB:5C40}.
FT   HELIX       200    207       {ECO:0000244|PDB:5C40}.
FT   HELIX       214    225       {ECO:0000244|PDB:5C40}.
FT   TURN        226    228       {ECO:0000244|PDB:5C40}.
FT   STRAND      230    235       {ECO:0000244|PDB:5C40}.
FT   HELIX       237    239       {ECO:0000244|PDB:5C40}.
FT   STRAND      241    247       {ECO:0000244|PDB:5C40}.
FT   STRAND      252    254       {ECO:0000244|PDB:5C40}.
FT   HELIX       267    281       {ECO:0000244|PDB:5C40}.
FT   HELIX       287    301       {ECO:0000244|PDB:5C40}.
FT   STRAND      304    306       {ECO:0000244|PDB:5C40}.
FT   HELIX       307    310       {ECO:0000244|PDB:5C40}.
FT   HELIX       314    316       {ECO:0000244|PDB:5C40}.
FT   HELIX       319    322       {ECO:0000244|PDB:5C40}.
SQ   SEQUENCE   322 AA;  34143 MW;  50D0E7161F33E94B CRC64;
     MAASGEPQRQ WQEEVAAVVV VGSCMTDLVS LTSRLPKTGE TIHGHKFFIG FGGKGANQCV
     QAARLGAMTS MVCKVGKDSF GNDYIENLKQ NDISTEFTYQ TKDAATGTAS IIVNNEGQNI
     IVIVAGANLL LNTEDLRAAA NVISRAKVMV CQLEITPATS LEALTMARRS GVKTLFNPAP
     AIADLDPQFY TLSDVFCCNE SEAEILTGLT VGSAADAGEA ALVLLKRGCQ VVIITLGAEG
     CVVLSQTEPE PKHIPTEKVK AVDTTGAGDS FVGALAFYLA YYPNLSLEDM LNRSNFIAAV
     SVQAAGTQSS YPYKKDLPLT LF
//
